Methods for treating or preventing SARS-cov-2 infections and covid -19 with Anti-SARS-cov-2 spike glycoprotein antibodies
PH12022500028B1Active Publication Date: 2026-08-19REGENERON PHARMACEUTICALS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12022500028
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2022-11-21
- Publication Date
- 2026-08-19
- Estimated Expiration
- 2042-11-21
Abstract
The present invention provides methods for preventing and treating SARS-CoV-2 infections, COVID-19, or symptoms thereof. The methods of the invention feature the administration of one or more antigen-binding molecules (e.g., antibodies) that bind a surface protein of SARS-CoV-2 (e.g., spike protein).
Need to check novelty before this filing date? Find Prior Art